Back
Alessandro Maselli
President, Chief Executive Officer & Director, Catalent Inc

Catalent Senior Executives Announce Leadership Transition

🎥 Jan 05, 2022 📺 CatalentPharmaSolutions ⏱ 4m
Catalent recently announced that its Board of Directors has appointed Alessandro Maselli, currently President and Chief Operating Officer, as the company’s next President and Chief Executive Officer, effective July 1, 2022. Maselli will also join the company’s Board of Directors upon assuming his new role. Current Chair and Chief Executive Officer John Chiminski will remain in his present role until July 1, 2022, when he will assume the position of Executive Chair of the Board. Catalent. More products. Better treatments. Reliably supplied.™ Every molecule has a challenge. We have a solu...
Watch on YouTube

About Alessandro Maselli

On January 5, 2022, Catalent announced that its Board of Directors had appointed Alessandro Maselli, then President and Chief Operating Officer, to become the company’s next President and Chief Executive Officer, effective July 1, 2022. Maselli was also set to join the Board of Directors upon assuming the role. Outgoing CEO John Chiminski stated that the board had unanimously appointed Maselli, whom he described as an "outstanding leader" and "the perfect person to lead Catalen forward." Chiminski planned to remain as CEO until July 1, 2022, and then become Executive Chair of the Board. In remarks following the announcement, Maselli thanked Chiminski for his leadership and said the company had "great momentum and extraordinary foundations" to continue its track record of performance and growth. He attributed the company’s achievements to the "talent, commitment and dedication" of its employees and stated that the "recipe for success" would not change, emphasizing a strategy built on a "patient first" value and "excellence in quality and operations." Maselli said he would work with Chiminski to ensure business continuity until the leadership transition and expressed his commitment to making Catalent "a great place to work."

Source: AI-verified profile updated from Alessandro Maselli's recent appearances. Browse all interviews →

Transcript (2 segments)
J
John0:10
Today we're announcing our plans for the next chapter of our company story. On June 30th of this year, I'll step down as CEO of Catalent and focus my efforts on my role as Executive Chair of the Board. Our board has unanimously appointed Alessandro Maselli, Catalent's current President and Chief Operating Officer, to become our company's next President and Chief Executive Officer. I want to congratulate Alessandro on this well-deserved promotion, and I've asked him to say a few words as well. But first, I'd like to say what an honor it's been to serve as CEO of Catalent these past 12 years. I'd especially like to thank every member of the Catalent team. It's a privilege working alongside such talented, passionate, and dedicated individuals every day, and I'm excited to continue doing so as we head into 2022. Over the next six months, I'll continue to serve as CEO, executing our ambitious 2022 plans. Nothing changes for you and nothing changes for me. I will, however, begin working with Alessandro to ensure a smooth transition as he becomes Catalent's next CEO on July 1st, 2022. I've worked alongside Alessandro for a great place to work. He is the perfect person to lead Catalent forward. Alessandro, over to you.
A
Alessandro Maselli2:21
Thank you, John. I wanted to thank you and congratulate you on an incredible tenure as CEO. Under your leadership and guidance, Catalent has undergone several transformations, becoming a leading provider of pharmaceutical services and a company we are all proud of. This is a very exciting day for me. The company has such great momentum and extraordinary foundations to continue the track record of high performance and growth we have set in place. I look forward to engaging and enabling them to build an even more successful future for Catalent. Our recipe for success will not change. We have a great and ambitious strategy, we have an outstanding team to execute it, and we have a strong culture relying on our values, the first and foremost of which is patient first. Excellence in quality and operations has been, since day one, the formula for success that John has brought together. We will continue to build that future on these foundations. As John said, until the leadership change in July, we will be working together. Done for this company, and I look forward to continuing our partnership in our new roles. I love Catalent. I love what we do for patients, I love why we do it, I love how we do it, and I will relentlessly work to make Catalent a great place to work which every one of you will be proud of. Stay safe, stay healthy, happy new year, and ciao.